Inspire Investing’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding BCRX
JHC
Inspire Investing's BCRX Position: Q3 2026 in Review
Inspire Investing increased its BioCryst Pharmaceuticals (BCRX) stake by 426% in Q3 2026, buying an estimated $2.77M and bringing the position to 362,878 shares worth $3.02M. The position accounts for 0.13% of the portfolio, ranked #181.
Inspire Investing first reported a position in BCRX in Q3 2022 and has held it in 17 quarters since. 334 funds tracked by Wall St. Rank hold BCRX as of Q3 2026.
- Inspire Investing held 362,878 shares of BioCryst Pharmaceuticals worth $3.02M as of Q3 2026.
- Inspire Investing bought 293,899 BioCryst Pharmaceuticals shares in Q3 2026, an estimated $2.77M.
- BioCryst Pharmaceuticals made up 0.13% of Inspire Investing's portfolio in Q3 2026, its #181 holding.
- Inspire Investing first reported a position in BioCryst Pharmaceuticals in Q3 2022 and has held it in 17 quarters since.
- 334 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q3 2026.
Based on Inspire Investing's 13F filing for Q3 2026, filed 22 Oct 2026.